X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (35) 35
humans (35) 35
male (32) 32
middle aged (32) 32
adult (25) 25
gastroenterology and hepatology (21) 21
gastroenterology & hepatology (20) 20
aged (15) 15
hepatitis c (13) 13
index medicus (11) 11
treatment outcome (10) 10
hepacivirus - genetics (9) 9
hepatitis (9) 9
hepatitis c, chronic - drug therapy (9) 9
drug therapy, combination (8) 8
recombinant proteins (8) 8
risk factors (8) 8
genotype (7) 7
hepatitis c, chronic - virology (7) 7
interferon (7) 7
prospective studies (7) 7
quality of life (7) 7
antiviral agents - administration & dosage (6) 6
antiviral agents - adverse effects (6) 6
interferon-alpha - therapeutic use (6) 6
transplantation (6) 6
abridged index medicus (5) 5
antiviral agents (5) 5
antiviral agents - therapeutic use (5) 5
double-blind method (5) 5
drug therapy (5) 5
fibrosis (5) 5
genotype & phenotype (5) 5
hepatitis c virus (5) 5
interferon-alpha - administration & dosage (5) 5
polyethylene glycols - therapeutic use (5) 5
ribavirin (5) 5
ribavirin - administration & dosage (5) 5
rna, viral - blood (5) 5
steatohepatitis (5) 5
surgery (5) 5
therapy (5) 5
viral load (5) 5
virus-infection (5) 5
biological response modifiers (4) 4
care and treatment (4) 4
chronic hepatitis-c (4) 4
fatty liver - complications (4) 4
health aspects (4) 4
interferon-alpha (4) 4
life sciences (4) 4
liver cirrhosis (4) 4
liver cirrhosis - diagnosis (4) 4
medicine, general & internal (4) 4
natural-history (4) 4
polyethylene glycols - administration & dosage (4) 4
proline - analogs & derivatives (4) 4
retrospective studies (4) 4
ribavirin - therapeutic use (4) 4
risk assessment (4) 4
risk-factors (4) 4
severity of illness index (4) 4
analysis (3) 3
article (3) 3
biomarkers - blood (3) 3
biopsy (3) 3
cardiac & cardiovascular systems (3) 3
chronic disease (3) 3
cirrhosis (3) 3
clinical trials (3) 3
disease progression (3) 3
dosage and administration (3) 3
dose-response relationship, drug (3) 3
drug administration schedule (3) 3
fatty liver - pathology (3) 3
hcv (3) 3
hepacivirus (3) 3
hepacivirus - drug effects (3) 3
hepacivirus - isolation & purification (3) 3
hepatitis c - drug therapy (3) 3
hepatitis c, chronic - complications (3) 3
immunology (3) 3
interferon-alpha - adverse effects (3) 3
liver - pathology (3) 3
liver cirrhosis - etiology (3) 3
liver cirrhosis - pathology (3) 3
liver diseases (3) 3
logistic models (3) 3
medical colleges (3) 3
of-life (3) 3
peginterferon alpha-2b (3) 3
plus ribavirin (3) 3
polyethylene glycols - adverse effects (3) 3
primary biliary-cirrhosis (3) 3
probability (3) 3
proline - adverse effects (3) 3
proline - therapeutic use (3) 3
proportional hazards models (3) 3
rna (3) 3
surveys and questionnaires (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 13, pp. 1207 - 1217
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2007, Volume 356, Issue 4, pp. 335 - 347
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 13, pp. 1195 - 1206
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 05/2015, Volume 313, Issue 17, pp. 1728 - 1735
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2/2007, Volume 44, Issue 4, pp. 607 - 614
Journal Article
Hepatology, ISSN 0270-9139, 08/2012, Volume 56, Issue 2, pp. 567 - 575
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 143, Issue 3, pp. 608 - 618.e5
Background & Aims Little is known about factors associated with a sustained virologic response (SVR) among patients with hepatitis C virus (HCV) infection to... 
Gastroenterology and Hepatology | Genetic | Response to Therapy | Clinical Trial | Prognostic Factors | GENETIC-VARIATION | IL28B | PLUS RIBAVIRIN | PEGINTERFERON ALPHA-2B | GENOTYPE 1 INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Recombinant Proteins - therapeutic use | Multivariate Analysis | Prospective Studies | Hepatitis C - drug therapy | United States | Humans | Hepacivirus - genetics | Male | RNA, Viral - blood | Polyethylene Glycols - therapeutic use | Viral Load | Interleukins - genetics | Time Factors | Adult | Female | Drug Therapy, Combination | Odds Ratio | Hepacivirus - drug effects | Proline - analogs & derivatives | Risk Assessment | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Risk Factors | Interferon-alpha - therapeutic use | Genotype | Hepatitis C - genetics | Logistic Models | Treatment Outcome | Biomarkers - blood | Canada | Hepatitis C - diagnosis | Proline - therapeutic use | Phenotype | Interferon alpha-2 | Hepacivirus - growth & development | Polymorphism, Single Nucleotide | Virus diseases | Medical research | Medical colleges | Interleukins | Protease inhibitors | Medicine, Experimental | Thrombin | Rivers | Biological response modifiers | Hepatitis C virus | Health aspects | Consulting services | Analysis | Biological Markers | Proline | Recombinant Proteins | Ribavirin | Life Sciences | Hépatology and Gastroenterology | Polyethylene Glycols | Interferon-alpha | Antiviral Agents | Human health and pathology | RNA, Viral | Hepatitis C | Hepacivirus
Journal Article
Clinical Case Reports, ISSN 2050-0904, 07/2016, Volume 4, Issue 7, pp. 653 - 656
Key Clinical Message There is currently minimal clinical experience regarding retreatment options for patients failing direct‐acting antiviral combination... 
Asunaprevir | HCV | daclatasvir | retreatment | Antiretroviral drugs | Genotype & phenotype | Hepatitis | Infections | Patients
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 07/2001, Volume 96, Issue 7, pp. 2199 - 2205
OBJECTIVE: The type and severity of chronic liver disease may have different effects on health-related quality of life (HRQL). The aim of our study was to... 
OUTCOMES | MODEL | GASTROENTEROLOGY & HEPATOLOGY | PRIMARY BILIARY-CIRRHOSIS | OF-LIFE | Liver Cirrhosis - diagnosis | Age Factors | Cholestasis, Intrahepatic - diagnosis | Humans | Middle Aged | Sex Factors | Quality of Life | Female | Liver Diseases - diagnosis | Male | Chronic Disease | Hepatitis, Viral, Human - diagnosis
Journal Article
Hepatology, ISSN 0270-9139, 07/2011, Volume 54, Issue 1, pp. 70 - 78
Journal Article